|
Oct 3
|
HLN or PODD: Which Is the Better Value Stock Right Now?
|
|
Oct 1
|
Fidelity Growth Strategies Fund Trimmed Insulet Corporation (PODD) to Manage the Position Size
|
|
Sep 30
|
Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024
|
|
Sep 27
|
Insulet's (NASDAQ:PODD) investors will be pleased with their respectable 48% return over the last five years
|
|
Aug 30
|
Here's Why We Think Insulet (NASDAQ:PODD) Is Well Worth Watching
|
|
Aug 30
|
Why Insulet Stock Was Zooming Higher This Week
|
|
Aug 27
|
S&P 500 Gains and Losses Today: Medical Device Makers ResMed, Insulet Lead Index
|
|
Aug 27
|
Sector Update: Health Care Stocks Edge Higher in Late Afternoon
|
|
Aug 27
|
Top Stock Movers Now: Nvidia, Insulet, Paramount Global, and More
|
|
Aug 27
|
This Healthcare Stock Is the Best Performer in the S&P 500 After FDA Approval
|
|
Aug 27
|
Insulet's Omnipod 5 Wins FDA Approval for Type 2 Diabetes
|
|
Aug 27
|
Insulet’s Trang Ly on overcoming ‘clinical inertia’ in diabetes care
|
|
Aug 27
|
Insulet Omnipod cleared by FDA for type 2 diabetes
|
|
Aug 26
|
Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes
|
|
Aug 26
|
Insulet expands Omnipod 5 pump to people with Type 2 diabetes
|
|
Jul 26
|
Are Ozempic Jitters to Blame for DexCom's Stock-Price Plunge?
|
|
Jul 26
|
Insulet Reports Preliminary Second Quarter 2024 Revenue Results
|
|
Jun 20
|
Insulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands
|
|
Jun 20
|
Insulet Announces Omnipod 5 Launch in France and U.S. Innovation Updates
|
|
Jun 17
|
Insider Sale at Insulet Corp (PODD) by SVP & Chief Technology Officer Mark Field
|